ArticlePharmaceutics2022

Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma.

Nami Tateyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.